Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 5

    1.

    Will diverse Tat interactions lead to novel antiretroviral drug targets?

    Harrich D, McMillan N, Munoz L, Apolloni A, Meredith L.

    Curr Drug Targets. 2006 Dec;7(12):1595-606. Review.

    PMID:
    17168834
    [PubMed - indexed for MEDLINE]
    2.

    The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention.

    Stevens M, De Clercq E, Balzarini J.

    Med Res Rev. 2006 Sep;26(5):595-625. Review.

    PMID:
    16838299
    [PubMed - indexed for MEDLINE]
    3.

    HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB.

    Wong K, Sharma A, Awasthi S, Matlock EF, Rogers L, Van Lint C, Skiest DJ, Burns DK, Harrod R.

    J Biol Chem. 2005 Mar 11;280(10):9390-9. Epub 2004 Dec 15.

    PMID:
    15611041
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication.

    Brès V, Kiernan R, Emiliani S, Benkirane M.

    J Biol Chem. 2002 Jun 21;277(25):22215-21. Epub 2002 Apr 15.

    PMID:
    11956210
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat.

    Benkirane M, Chun RF, Xiao H, Ogryzko VV, Howard BH, Nakatani Y, Jeang KT.

    J Biol Chem. 1998 Sep 18;273(38):24898-905.

    PMID:
    9733796
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk